Investigating the Safety and Efficacy, Quality of Life, Cost-Efficiency and Immune Potential of High Precision Lung Radiotherapy

Stereotactic Ablative Fractionated Radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomized Phase II Trial

S Siva, M Bressel, T Kron, T Mai, HV Le, R Montgomery, N Hardcastle, A Rezo, S Gill, BG Higgs, DI Pryor, R De Abreu Lourenco, R Awad, B Chesson, TN Eade, M Skala, G Sasso, W Wong, S Vinod, D Ball

2020-11-01

A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

S Siva, T Kron, M Bressel, M Haas, T Mai, S Vinod, G Sasso, W Wong, H Le, T Eade, N Hardcastle, B Chesson, D Pham, M Høyer, R Montgomery, D Ball

2016-03-04

Background: Stereotactic ablative body radiotherapy (SABR) is emerging as a non-invasive method for precision irradiation of lung ..